Articles in this database are automatically generated by our AI system based on data from the Digicomply APP. While we strive for accuracy, the articles may not contain complete or verified information and are intended for informational purposes only. For accurate and reliable information, we recommend using SGS Digicomply or consulting verified sources and experts. All content is copyrighted; please credit SGS Digicomply (digicomply.com) when sharing.
On February 18, 2025, the U.S. Food and Drug Administration (FDA) reported an incident concerning the Dermo jet needleless injector. The issue pertains to inaccurate labeling identified on the product, which has been categorized under adulteration in the hazard category.
The Dermo jet needleless injector is designed for delivering medications without the use of traditional needles, thereby minimizing the risk of needle-stick injuries. However, the presence of inaccurate labeling raises concerns regarding the product's reliability and the potential implications for both healthcare providers and patients.
This incident has been classified as an other incident, indicating that it does not fall under conventional recall categories but still necessitates attention due to the risks associated with the misrepresentation of product information. The FDA's involvement highlights the regulatory oversight necessary to ensure that medical devices meet established safety and efficacy standards.
Consumers and healthcare professionals are advised to remain vigilant regarding the labeling of medical products and to report any discrepancies they observe. The FDA continues to monitor the situation and will provide updates as necessary to ensure public safety related to the Dermo jet needleless injector.
- Incident: Inaccurate Labeling has been detected in Dermo jet needleless injector.
- Date: 2025-02-18
- Product: Dermo jet needleless injector
- Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
- Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
- Incident Category: Other incident
- Hazard Category: Adulteration
- Source: U.S. Food and Drug Administration
For more detailed information about this and other similar incidents, with access to filtering options, historical data, and trend analysis, try the SGS Digicomply Food Safety Software.
Explore SGS Digicomply Food Safety Intelligence Hub demos here. (for enterprises only, no individual plans)
